JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Horishita, T. Articles by Harris, R. A. PubMed PubMed Citation Articles by Horishita, T. Articles by Harris, R. A. Related Collections Mechanisms Preclinical Pharmacology Pharmacology

---

ANESTHETIC PHARMACOLOGY

The Effects of Volatile Aromatic Anesthetics on Voltage-Gated Na⁺ Channels Expressed in Xenopus Oocytes

Takafumi Horishita, MD, PhD^*, Edmond I. Eger, II, MD, and R. Adron Harris, PhD^*

From the *Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, Texas; and Department of Anesthesia and Perioperative Care, University of California, San Francisco, California.

Address correspondence and reprint requests to R. Adron Harris, PhD, Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, 1 University Station A4800, Austin, TX 78712. Address e-mail to harris{at}mail.utexas.edu.

BACKGROUND: Many inhaled anesthetics inhibit voltage-gated sodium channels at clinically relevant concentrations, and suppression of neurotransmitter release by these anesthetics results, at least partly, from decreased presynaptic sodium channel activity. Volatile aromatic anesthetics can inhibit N-methyl-d-aspartate (NMDA) receptor function and enhance -amino butyric acid A receptor function, but these effects depend strongly on the chemical properties of the aromatic compounds. In the present study we tested whether diverse aromatic anesthetics consistently inhibit sodium channel function.

METHODS: We studied the effect of eight aromatic anesthetics on Na_v1.2 sodium channels with β₁ subunits, using whole-cell, two-electrode voltage-clamp techniques in Xenopus oocytes.

RESULTS: All aromatic anesthetics inhibited I_Na (sodium currents) at a holding potential which produce half-maximal current (V_1/2) (partial depolarization); inhibition was modest with 1,3,5-trifluorobenzene (8% ± 2%), pentafluorobenzene (13% ± 2%), and hexafluorobenzene (13% ± 2%), but greater with benzene (37% ± 2%), fluorobenzene (39% ± 2%), 1,2-difluorobenzene (48% ± 2%), 1,4-difluorobenzene (31 ± 3%), and 1,2,4-trifluorobenzene (33% ± 1%). Such dichotomous effects were noted by others for NMDA and -aminobutyric acid A receptors. Parallel, but much smaller inhibition, was found for I_Na at a holding potential which produced near maximal current (–90 mV) (V_H-90), and hexafluorobenzene caused small (6% ± 1%) enhancement of this current. These changes in sodium channel function were correlated with effectiveness for inhibiting NMDA receptors, with lipid solubility of the compounds, with molecular volume, and with cation- interactions.

CONCLUSION: Aromatic compounds vary in their actions on the kinetics of sodium channel gating and this may underlie their variable inhibition. The range of inhibition produced by minimum alveolar anesthetic concentration concentrations of inhaled anesthetics indicates that sodium channel inhibition may underlie the action of some of these anesthetics, but not others.

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999